Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Nutrition and Cancer|October 18, 2022
Diet Influences Immunotherapy Outcomes in Cancer Patients: A Literature ReviewNaghmeh Kian, Sadra Behrouzieh, Sepideh Razi, et al.Cytokine|November 23, 2021
TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends?Azadeh Sadat Razavi, Maryam Mohtashami, Sepideh Razi, et al.International Immunopharmacology|January 26, 2023
The signaling and the metabolic differences of various CAR T cell designsAzadeh Sadat Razavi, Angelica Loskog, Sepideh Razi, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 5, 2022
AMPK's double-faced role in advanced stages of prostate cancerFaeze Gharibpoor, Sara Kamali Zonouzi, Sepideh Razi, et al.Expert Review of Anticancer Therapy|November 25, 2021
The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapiesFateme Sheida, Sepideh Razi, Mahsa Keshavarz-Fathi, et al.International Immunopharmacology|April 24, 2023
Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatmentGita Manzari Tavakoli, Mohammad Hossein Mirzapour, Sepideh Razi, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 22, 2022
The pro-tumorigenic responses in metastatic niches: an immunological perspectiveMohammad Hossein Mirzapour, Mahsa Heidari-Foroozan, Sepideh Razi, et al.Cytokine|January 27, 2019
IL-17 and colorectal cancer: From carcinogenesis to treatmentSepideh Razi, Behnoud Baradaran Noveiry, Mahsa Keshavarz-Fathi, et al.Clinical and Experimental Medicine|April 25, 2025
The role of CXC chemokines and receptors in breast cancerMahdi Masrour, Aysan Moeinafshar, Amirhossein Poopak, et al.Journal of Immunology Research|March 8, 2021
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer ImmunotherapyRangarirai Makuku, Neda Khalili, Sepideh Razi, et al.Pageof 4